Symbotic (NASDAQ: SYM) is automating large warehouses and distribution centers with its artificial-intelligence (AI)-powered automated robotic systems.
Supply chain automation is a rapidly growing market, Symbotic’s revenue is rising steadily, and it signed medical surgical products leader, Medline as its first customer from the healthcare sector in April
Yet, Symbotic stock slumped 21.4% in May, according to data provided by S&P Global Market Intelligence. Shares have fallen further this month and touched their lowest levels in 2026, as of this writing. Should investors panic or buy the dip?
Why Symbotic stock is falling despite bumper numbers Symbotic’s revenue rose 23% year over year in Q2, and it reported a net income of $9 million versus a loss of $10 million in the year-ago quarter. That dramatic improvement in profits should have sent the stock higher, but Wall Street was fixated on the one cent in profit per share. They expected something much bigger from the company.